{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T01:27:39Z","timestamp":1788658059050,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":335,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1124\/jpet.123.002040","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T19:15:34Z","timestamp":1705518934000},"page":"260-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Progress and Challenges in Developing Medical Countermeasures for Chemical, Biological, Radiological, and Nuclear Threat Agents"],"prefix":"10.1016","volume":"388","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2735-9550","authenticated-orcid":false,"given":"Doodipala Samba","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.123.002040_bib1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1124\/jpet.123.001666","article-title":"Pharmacologic Inhibition of TRPA1 Counteract CS Tear Gas Agent-induced Cutaneous Injuries","volume":"388","author":"Achanta","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1124\/jpet.123.001836","article-title":"Evidence implicating blood-brain barrier impairment in the pathogenesis of acquired epilepsy following acute organophosphate intoxication","volume":"388","author":"Bernardino","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1124\/jpet.123.001739","article-title":"Comparison of spontaneous recurrent seizures in rats following status epilepticus induced by organophosphate paraoxon, DFP, and Sarin","volume":"388","author":"Blair","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib4","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm1013-1194","article-title":"Syrian gas attack reinforces need for better anti-sarin drugs","volume":"19","author":"Dolgin","year":"2013","journal-title":"Nat Med"},{"key":"10.1124\/jpet.123.002040_bib5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1124\/jpet.123.001710","article-title":"Preventing Long-Term Brain Damage by Nerve Agent-induced Status Epilepticus in Rat Models Applicable to Infants: Significant Neuroprotection by Tezampanel Combined with Caramiphen but not by Midazolam Treatment","volume":"388","author":"Furtado","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib6","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1124\/jpet.123.001718","article-title":"Dermal Exposure to Vesicating Nettle Agent Phosgene Oxime: Clinically Relevant Biomarkers and Skin Injury Progression in Murine Models","volume":"388","author":"Goswami","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1124\/jpet.123.001832","article-title":"[11C]Paraoxon: Radiosynthesis, Biodistribution and In Vivo Positron Emission Tomography (PET) Imaging in Rat","volume":"388","author":"Hayes","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nyas.13179","article-title":"The NIH Countermeasures Against Chemical Threats Program: overview and special challenges","volume":"1374","author":"Jett","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.123.002040_bib9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1080\/10408444.2020.1787330","article-title":"A national toxicology program systematic review of the evidence for long-term effects after acute exposure to sarin nerve agent","volume":"50","author":"Jett","year":"2020","journal-title":"Crit Rev Toxicol"},{"key":"10.1124\/jpet.123.002040_bib10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1124\/jpet.123.001708","article-title":"Novel Catalytic Antioxidant Formulations Decrease Oxidative Stress, Neuroinflammation and Cognitive Dysfunction in a model of Nerve Agent Intoxication","volume":"388","author":"Liang","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1124\/jpet.123.001789","article-title":"Efficacy of lacosamide and rufinamide as adjuncts to midazolam-ketamine treatment against cholinergic induced status epilepticus in rats","volume":"388","author":"Lumley","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib12","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1124\/jpet.123.001822","article-title":"Countermeasures against pulmonary threat agents","volume":"388","author":"Marzec","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1124\/jpet.123.001773","article-title":"Aminopyridines Restore Ventilation and Reverse Respiratory Acidosis at Late Stages of Botulism in Mice","volume":"388","author":"McClintic","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib14","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1124\/jpet.123.001557","article-title":"Suppression of lung oxidative stress, inflammation and fibrosis following nitrogen mustard exposure by the selective farnesoid X receptor agonist obeticholic acid","volume":"388","author":"Meshanni","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1124\/jpet.123.001760","article-title":"Nitrogen mustard-induced ex vivo human cornea injury model and therapeutic intervention by dexamethasone","volume":"388","author":"Mishra","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.123.001680","article-title":"Establishing a dexamethasone treatment regimen to alleviate sulfur mustard-induced corneal injuries in a rabbit model","volume":"388","author":"Mishra","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1124\/jpet.123.001742","article-title":"Cutaneous arsenical exposure induces distinct metabolic transcriptional alterations of kidney cells","volume":"388","author":"Moore","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1124\/jpet.123.001763","article-title":"Long-term Neuropsychiatric Developmental Defects after Neonatal Organophosphate Exposure: Mitigation by Synthetic Neurosteroids","volume":"388","author":"Neff","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.fct.2018.09.015","article-title":"Chemical warfare agent NOVICHOK - mini-review of available data","volume":"121","author":"Nepovimova","year":"2018","journal-title":"Food Chem Toxicol"},{"key":"10.1124\/jpet.123.002040_bib20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1124\/jpet.123.001784","article-title":"Evaluation of Midazolam-Ketamine-Allopregnanolone Combination Therapy against Cholinergic-Induced Status Epilepticus in Rats","volume":"388","author":"Nguyen","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib21","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1124\/jpet.123.001683","article-title":"Mesna Improves Outcomes of Sulfur Mustard Inhalation Toxicity in an Acute Rat Model","volume":"388","author":"Nick","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0196-0644(96)70052-5","article-title":"Report on 640 victims of the Tokyo subway sarin attack","volume":"28","author":"Okumura","year":"1996","journal-title":"Ann Emerg Med"},{"key":"10.1124\/jpet.123.002040_bib23","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1124\/jpet.123.001697","article-title":"Differential Efficacy of Small Molecules Dynasore and Mdivi-1 for the Treatment of Dry Eye Epitheliopathy or as a Countermeasure for Nitrogen Mustard Exposure of the Ocular Surface","volume":"388","author":"Pan","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib24","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1124\/jpet.123.001719","article-title":"A Potential Antidote for both Azide and Cyanide Poisonings","volume":"388","author":"Pearce","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib25","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1124\/jpet.123.001714","article-title":"Oxidant-dependent Sensitizing, Protective and Mitigative Effects in X-ray Irradiated Pulmonary Endothelial Cells","volume":"388","author":"Pearce","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib26","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1124\/jpet.123.001721","article-title":"Strengthening Warfighter Resiliency Using Broad-Spectrum or Host-Directed Therapies within the Rapid Acquisition and Investigation of Drugs for Repurposing (RAIDR) Program","volume":"388","author":"Quattrochi","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib27","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1124\/jpet.123.001817","article-title":"Protective Activity of Novel Hydrophilic Synthetic Neurosteroids on Organophosphate Status Epilepticus-induced Chronic Epileptic Seizures, Non-Convulsive Discharges, High-Frequency Oscillations and Electrographic Ictal Biomarkers","volume":"388","author":"Ramakrishnan","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cotox.2019.08.001","article-title":"Mechanism-based novel antidotes for organophosphate neurotoxicity","volume":"14","author":"Reddy","year":"2019","journal-title":"Curr Opin Toxicol"},{"key":"10.1124\/jpet.123.002040_bib29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1124\/jpet.123.001816","article-title":"Neurosteroids as Novel Anticonvulsants for Refractory Status Epilepticus and Medical Countermeasures for Nerve Agents: A 15-Year-Long Journey to Bring Ganaxolone from Bench to Clinic","volume":"388","author":"Reddy","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/cts.12435","article-title":"A Comparative Toxidrome Analysis of Human Organophosphate and Nerve Agent Poisonings Using Social Media","volume":"10","author":"Reddy","year":"2017","journal-title":"Clin Transl Sci"},{"key":"10.1124\/jpet.123.002040_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1124\/jpet.123.001819","article-title":"Neuroprotectant Activity of Novel Water-Soluble Synthetic Neurosteroids on Organophosphate Intoxication and Status Epilepticus-induced Long-term Neurological Dysfunction, Neurodegeneration and Neuroinflammation","volume":"388","author":"Reddy","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108571","article-title":"Comparative profile of refractory status epilepticus models following exposure of cholinergic agents pilocarpine, DFP, and soman","volume":"191","author":"Reddy","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.123.002040_bib33","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/epi.12989","article-title":"Midazolam as an anticonvulsant antidote for organophosphate intoxication--A pharmacotherapeutic appraisal","volume":"56","author":"Reddy","year":"2015","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.002040_bib34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/nyas.14431","article-title":"Magnetic resonance imaging analysis of long-term neuropathology after exposure to the nerve agent soman: correlation with histopathology and neurological dysfunction","volume":"1480","author":"Reddy","year":"2020","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.123.002040_bib35","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1124\/jpet.123.001824","article-title":"Ketamine produces antidepressant effects by inhibiting histone deacetylases and upregulating hippocampal BDNF levels in a DFP-based rat model of Gulf War Illness","volume":"388","author":"Ribeiro-Davis","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1124\/jpet.123.001820","article-title":"Sarin-Induced Neuroinflammation in Mouse Brain is Attenuated by the Caspase Inhibitor Q-VD-Oph","volume":"388","author":"Shah","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib37","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1124\/jpet.123.001663","article-title":"Mitigation of nitrogen mustard-induced skin injury by the \u03b2 -blocker carvedilol and its enantiomers","volume":"388","author":"Shahid","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib38","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1124\/jpet.123.001686","article-title":"Treatment of Sulfur Mustard Corneal Injury by Augmenting the DNA Damage Response (DDR): A Novel Approach","volume":"388","author":"Shalwitz","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1124\/jpet.123.001747","article-title":"Sex Differences in Organophosphate Intoxication Model of Benzodiazepine-Refractory Status Epilepticus and Neuronal Damage","volume":"388","author":"Singh","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib40","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1124\/jpet.123.001794","article-title":"A Pediatric Rat Model of Organophosphate-Induced Refractory Status Epilepticus: Characterization of Long-term Epileptic Seizure Activity, Neurological Dysfunction and Neurodegeneration","volume":"388","author":"Singh","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib41","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1124\/jpet.123.001795","article-title":"HSP90, a common therapeutic target for suppressing skin injury caused by exposure to chemically diverse classes of blistering agents","volume":"388","author":"Srivastava","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(20)32644-1","article-title":"Novichok nerve agent poisoning","volume":"397","author":"Steindl","year":"2021","journal-title":"Lancet"},{"key":"10.1124\/jpet.123.002040_bib43","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/jpet.123.001780","article-title":"A murine model of vesicant-induced acute lung injury","volume":"388","author":"Zafar","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.002040_bib44","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1124\/jpet.123.001814","article-title":"The Involvement of Unfolded Protein Response in the Mechanism of Nitrogen Mustard-Induced Ocular Toxicity","volume":"388","author":"Zhylkibayev","year":"2024","journal-title":"J Pharmacol Exp Ther"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524171625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524171625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.123.002040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T22:07:38Z","timestamp":1743199658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524171625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0022356524171625"],"URL":"https:\/\/doi.org\/10.1124\/jpet.123.002040","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progress and Challenges in Developing Medical Countermeasures for Chemical, Biological, Radiological, and Nuclear Threat Agents","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.123.002040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The Author(s)","name":"copyright","label":"Copyright"}]}}